Literature DB >> 16641450

Stepwise upregulation of the Pseudomonas aeruginosa chromosomal cephalosporinase conferring high-level beta-lactam resistance involves three AmpD homologues.

Carlos Juan1, Bartolomé Moyá, José L Pérez, Antonio Oliver.   

Abstract

Development of resistance to the antipseudomonal penicillins and cephalosporins mediated by hyperproduction of the chromosomal cephalosporinase AmpC is a major threat to the successful treatment of Pseudomonas aeruginosa infections. Although ampD inactivation has been previously found to lead to a partially derepressed phenotype characterized by increased AmpC production but retaining further inducibility, the regulation of ampC in P. aeruginosa is far from well understood. We demonstrate that ampC expression is coordinately repressed by three AmpD homologues, including the previously described protein AmpD plus two additional proteins, designated AmpDh2 and AmpDh3. The three AmpD homologues are responsible for a stepwise ampC upregulation mechanism ultimately leading to constitutive hyperexpression of the chromosomal cephalosporinase and high-level antipseudomonal beta-lactam resistance, as shown by analysis of the three single ampD mutants, the three double ampD mutants, and the triple ampD mutant. This is achieved by a three-step escalating mechanism rendering four relevant expression states: basal-level inducible expression (wild type), moderate-level hyperinducible expression with increased antipseudomonal beta-lactam resistance (ampD mutant), high-level hyperinducible expression with high-level beta-lactam resistance (ampD ampDh3 double mutant), and very high-level (more than 1,000-fold compared to the wild type) derepressed expression (triple mutant). Although one-step inducible-derepressed expression models are frequent in natural resistance mechanisms, this is the first characterized example in which expression of a resistance gene can be sequentially amplified through multiple steps of derepression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16641450      PMCID: PMC1472203          DOI: 10.1128/AAC.50.5.1780-1787.2006

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  40 in total

1.  Transformation of Pseudomonas aeruginosa by electroporation.

Authors:  A W Smith; B H Iglewski
Journal:  Nucleic Acids Res       Date:  1989-12-25       Impact factor: 16.971

Review 2.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

3.  Rapid emergence of resistance in Pseudomonas aeruginosa in cystic fibrosis patients due to in-vivo selection of stable partially derepressed beta-lactamase producing strains.

Authors:  B Giwercman; P A Lambert; V T Rosdahl; G H Shand; N Høiby
Journal:  J Antimicrob Chemother       Date:  1990-08       Impact factor: 5.790

4.  Regulation of enterobacterial cephalosporinase production: the role of a membrane-bound sensory transducer.

Authors:  N Honoré; M H Nicolas; S T Cole
Journal:  Mol Microbiol       Date:  1989-08       Impact factor: 3.501

Review 5.  beta-Lactamases in laboratory and clinical resistance.

Authors:  D M Livermore
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

6.  Investigation of the Pseudomonas aeruginosa ampR gene and its role at the chromosomal ampC beta-lactamase promoter.

Authors:  J Lodge; S Busby; L Piddock
Journal:  FEMS Microbiol Lett       Date:  1993-08-01       Impact factor: 2.742

7.  Construction of improved Escherichia-Pseudomonas shuttle vectors derived from pUC18/19 and sequence of the region required for their replication in Pseudomonas aeruginosa.

Authors:  S E West; H P Schweizer; C Dall; A K Sample; L J Runyen-Janecky
Journal:  Gene       Date:  1994-10-11       Impact factor: 3.688

Review 8.  Development of resistance during antimicrobial therapy: a review of antibiotic classes and patient characteristics in 173 studies.

Authors:  D N Fish; S C Piscitelli; L H Danziger
Journal:  Pharmacotherapy       Date:  1995 May-Jun       Impact factor: 4.705

9.  The negative regulator of beta-lactamase induction AmpD is a N-acetyl-anhydromuramyl-L-alanine amidase.

Authors:  J V Höltje; U Kopp; A Ursinus; B Wiedemann
Journal:  FEMS Microbiol Lett       Date:  1994-09-15       Impact factor: 2.742

10.  Bacterial cell wall recycling provides cytosolic muropeptides as effectors for beta-lactamase induction.

Authors:  C Jacobs; L J Huang; E Bartowsky; S Normark; J T Park
Journal:  EMBO J       Date:  1994-10-03       Impact factor: 11.598

View more
  79 in total

1.  Increased expression of ampC in Pseudomonas aeruginosa mutants selected with ciprofloxacin.

Authors:  Daniel J Wolter; Amber J Schmidtke; Nancy D Hanson; Philip D Lister
Journal:  Antimicrob Agents Chemother       Date:  2007-05-21       Impact factor: 5.191

2.  Induction of L1 and L2 beta-lactamase production in Stenotrophomonas maltophilia is dependent on an AmpR-type regulator.

Authors:  Aki Okazaki; Matthew B Avison
Journal:  Antimicrob Agents Chemother       Date:  2008-01-22       Impact factor: 5.191

3.  Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.

Authors:  Esther Viedma; Carlos Juan; Joshi Acosta; Laura Zamorano; Joaquín R Otero; Francisca Sanz; Fernando Chaves; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2009-09-08       Impact factor: 5.191

4.  Identification of novel genes responsible for overexpression of ampC in Pseudomonas aeruginosa PAO1.

Authors:  Yuko Tsutsumi; Haruyoshi Tomita; Koichi Tanimoto
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

5.  Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutation.

Authors:  B Henrichfreise; I Wiegand; W Pfister; B Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  2007-09-17       Impact factor: 5.191

6.  The β-lactamase gene regulator AmpR is a tetramer that recognizes and binds the D-Ala-D-Ala motif of its repressor UDP-N-acetylmuramic acid (MurNAc)-pentapeptide.

Authors:  Grishma Vadlamani; Misty D Thomas; Trushar R Patel; Lynda J Donald; Thomas M Reeve; Jörg Stetefeld; Kenneth G Standing; David J Vocadlo; Brian L Mark
Journal:  J Biol Chem       Date:  2014-12-05       Impact factor: 5.157

7.  Influence of high mutation rates on the mechanisms and dynamics of in vitro and in vivo resistance development to single or combined antipseudomonal agents.

Authors:  V Plasencia; N Borrell; M D Maciá; B Moya; J L Pérez; A Oliver
Journal:  Antimicrob Agents Chemother       Date:  2007-04-30       Impact factor: 5.191

8.  Activity of a new cephalosporin, CXA-101 (FR264205), against beta-lactam-resistant Pseudomonas aeruginosa mutants selected in vitro and after antipseudomonal treatment of intensive care unit patients.

Authors:  Bartolome Moya; Laura Zamorano; Carlos Juan; José L Pérez; Yigong Ge; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

9.  The Pseudomonas aeruginosa CreBC two-component system plays a major role in the response to β-lactams, fitness, biofilm growth, and global regulation.

Authors:  Laura Zamorano; Bartolomé Moyà; Carlos Juan; Xavier Mulet; Jesús Blázquez; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2014-06-16       Impact factor: 5.191

10.  Changes to its peptidoglycan-remodeling enzyme repertoire modulate β-lactam resistance in Pseudomonas aeruginosa.

Authors:  Joseph F Cavallari; Ryan P Lamers; Edie M Scheurwater; Andrea L Matos; Lori L Burrows
Journal:  Antimicrob Agents Chemother       Date:  2013-04-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.